Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 46

1.

Age at first intercourse, number of partners and STI prevalence among Danish, Norwegian and Swedish women: estimates and trends from nationally representative cross-sectional surveys of more than 100 000 women.

Hansen BT, Kjaer SK, Arnheim-Dahlström L, Liaw KL, Juul KE, Thomsen LT, Frederiksen K, Elfström KM, Munk C, Nygård M.

Acta Obstet Gynecol Scand. 2019 Sep 16. doi: 10.1111/aogs.13732. [Epub ahead of print]

PMID:
31529491
2.

Patient journey and treatment patterns in adults with IPF based on health care data in Sweden from 2001 to 2015.

Sköld CM, Arnheim-Dahlström L, Bartley K, Janson C, Kirchgaessler KU, Levine A, Ferrara G.

Respir Med. 2019 Aug;155:72-78. doi: 10.1016/j.rmed.2019.06.001. Epub 2019 Jun 5.

3.

Effectiveness of the herpes zoster vaccine Zostavax® in Stockholm County, Sweden.

Blom K, Yin L, Arnheim-Dahlström L.

Vaccine. 2019 Jul 18;37(31):4401-4406. doi: 10.1016/j.vaccine.2019.06.008. Epub 2019 Jun 21.

4.

Contraceptive use at first intercourse is associated with subsequent sexual behaviors.

Guleria S, Thomsen LT, Munk C, Nygård M, Hansen BT, Elfström KM, Arnheim-Dahlström L, Liaw KL, Frederiksen K, Kjær SK.

Contraception. 2019 Apr;99(4):217-221. doi: 10.1016/j.contraception.2018.12.006. Epub 2019 Jan 23.

PMID:
30684469
5.

Mode of HPV vaccination delivery and equity in vaccine uptake: A nationwide cohort study.

Wang J, Ploner A, Sparén P, Lepp T, Roth A, Arnheim-Dahlström L, Sundström K.

Prev Med. 2019 Mar;120:26-33. doi: 10.1016/j.ypmed.2018.12.014. Epub 2018 Dec 27.

6.

Incidence rates of narcolepsy diagnoses in Taiwan, Canada, and Europe: The use of statistical simulation to evaluate methods for the rapid assessment of potential safety issues on a population level in the SOMNIA study.

Dodd CN, de Ridder M, Huang WT, Weibel D, Giner-Soriano M, Perez-Vilar S, Diez-Domingo J, Svenson LW, Mahmud SM, Carleton B, Naus M, Kwong JC, Murray BJ, Arnheim-Dahlstrom L, Pedersen L, Morros R, Puertas FJ, Black S, Sturkenboom M.

PLoS One. 2018 Oct 17;13(10):e0204799. doi: 10.1371/journal.pone.0204799. eCollection 2018.

7.

Effectiveness of varying number of doses and timing between doses of quadrivalent HPV vaccine against severe cervical lesions.

Dehlendorff C, Sparén P, Baldur-Felskov B, Herweijer E, Arnheim-Dahlström L, Ploner A, Uhnoo I, Kjaer SK.

Vaccine. 2018 Oct 15;36(43):6373-6378. doi: 10.1016/j.vaccine.2018.09.011. Epub 2018 Sep 21.

PMID:
30249423
8.

Differential uptake of herpes zoster vaccination associated with socioeconomic status: A population-based study in Stockholm County, Sweden.

Fogelberg S, Lamb F, Grönlund O, Eriksson I, Sundström K, Clements M, Arnheim-Dahlström L.

Pharmacoepidemiol Drug Saf. 2018 Nov;27(11):1159-1165. doi: 10.1002/pds.4653. Epub 2018 Sep 17. Review. Erratum in: Pharmacoepidemiol Drug Saf. 2019 Mar;28(3):401.

PMID:
30221421
9.

Narcolepsy and adjuvanted pandemic influenza A (H1N1) 2009 vaccines - Multi-country assessment.

Weibel D, Sturkenboom M, Black S, de Ridder M, Dodd C, Bonhoeffer J, Vanrolleghem A, van der Maas N, Lammers GJ, Overeem S, Gentile A, Giglio N, Castellano V, Kwong JC, Murray BJ, Cauch-Dudek K, Juhasz D, Campitelli M, Datta AN, Kallweit U, Huang WT, Huang YS, Hsu CY, Chen HC, Giner-Soriano M, Morros R, Gaig C, Tió E, Perez-Vilar S, Diez-Domingo J, Puertas FJ, Svenson LW, Mahmud SM, Carleton B, Naus M, Arnheim-Dahlström L, Pedersen L, DeStefano F, Shimabukuro TT.

Vaccine. 2018 Oct 1;36(41):6202-6211. doi: 10.1016/j.vaccine.2018.08.008. Epub 2018 Aug 16.

10.

Self-perceived risk of STIs in a population-based study of Scandinavian women.

Guleria S, Faber MT, Hansen BT, Arnheim-Dahlström L, Liaw KL, Munk C, Nygård M, Kjær SK.

Sex Transm Infect. 2018 Nov;94(7):522-527. doi: 10.1136/sextrans-2017-053397. Epub 2018 Mar 9.

PMID:
29523719
11.

Human papillomavirus vaccination of adult women and risk of autoimmune and neurological diseases.

Hviid A, Svanström H, Scheller NM, Grönlund O, Pasternak B, Arnheim-Dahlström L.

J Intern Med. 2018 Feb;283(2):154-165. doi: 10.1111/joim.12694. Epub 2017 Oct 18.

PMID:
29044769
12.

Antibody Affinity Against 2009 A/H1N1 Influenza and Pandemrix Vaccine Nucleoproteins Differs Between Childhood Narcolepsy Patients and Controls.

Lind A, Freyhult E, Ramelius A, Olsson T, Arnheim-Dahlström L, Lamb F, Khademi M, Ambati A, Maeurer M, Lima Bomfim I, Fink K, Fex M, Törn C, Elding Larsson H, Lernmark Å.

Viral Immunol. 2017 Oct;30(8):590-600. doi: 10.1089/vim.2017.0066. Epub 2017 Aug 10.

PMID:
28796576
13.

Timing of two versus three doses of quadrivalent HPV vaccine and associated effectiveness against condyloma in Sweden: a nationwide cohort study.

Lamb F, Herweijer E, Ploner A, Uhnoo I, Sundström K, Sparén P, Arnheim-Dahlström L.

BMJ Open. 2017 Jun 8;7(6):e015021. doi: 10.1136/bmjopen-2016-015021.

14.

The immunogenetics of narcolepsy associated with A(H1N1)pdm09 vaccination (Pandemrix) supports a potent gene-environment interaction.

Bomfim IL, Lamb F, Fink K, Szakács A, Silveira A, Franzén L, Azhary V, Maeurer M, Feltelius N, Darin N, Hallböök T, Arnheim-Dahlström L, Kockum I, Olsson T.

Genes Immun. 2017 Mar;18(2):75-81. doi: 10.1038/gene.2017.1. Epub 2017 Mar 23.

PMID:
28332559
15.

Contraceptive non-use and emergency contraceptive use at first sexual intercourse among nearly 12 000 Scandinavian women.

Guleria S, Juul KE, Munk C, Hansen BT, Arnheim-Dahlström L, Liaw KL, Nygård M, Kjaer SK.

Acta Obstet Gynecol Scand. 2017 Mar;96(3):286-294. doi: 10.1111/aogs.13088. Epub 2017 Feb 11.

PMID:
28029175
16.

Authors' response: Letter to the Editor - HPV vaccine and autoimmunity.

Grönlund O, Herweijer E, Sundström K, Arnheim-Dahlström L.

J Intern Med. 2017 Mar;281(3):311-312. doi: 10.1111/joim.12574. Epub 2016 Nov 18. No abstract available.

17.

Management of women with human papillomavirus persistence: long-term follow-up of a randomized clinical trial.

Elfgren K, Elfström KM, Naucler P, Arnheim-Dahlström L, Dillner J.

Am J Obstet Gynecol. 2017 Mar;216(3):264.e1-264.e7. doi: 10.1016/j.ajog.2016.10.042. Epub 2016 Nov 5.

PMID:
27825977
18.

Sexually transmitted infections after bereavement - a population-based cohort study.

Bond E, Lu D, Herweijer E, Sundström K, Valdimarsdóttir U, Fall K, Arnheim-Dahlström L, Sparén P, Fang F.

BMC Infect Dis. 2016 Aug 15;16(1):419. doi: 10.1186/s12879-016-1705-x.

19.

Incidence of new-onset autoimmune disease in girls and women with pre-existing autoimmune disease after quadrivalent human papillomavirus vaccination: a cohort study.

Grönlund O, Herweijer E, Sundström K, Arnheim-Dahlström L.

J Intern Med. 2016 Dec;280(6):618-626. doi: 10.1111/joim.12535. Epub 2016 Jul 31.

20.

Autoantibody targets in vaccine-associated narcolepsy.

Häggmark-Månberg A, Zandian A, Forsström B, Khademi M, Lima Bomfim I, Hellström C, Arnheim-Dahlström L, Hallböök T, Darin N, Lundberg IE, Uhlén M, Partinen M, Schwenk JM, Olsson T, Nilsson P.

Autoimmunity. 2016 Sep;49(6):421-433. Epub 2016 May 20.

PMID:
27206786
21.

Awareness of human papillomavirus after introduction of HPV vaccination: a large population-based survey of Scandinavian women.

Thomsen LT, Nygård M, Stensen S, Terning Hansen B, Arnheim Dahlström L, Liaw KL, Munk C, Kjaer SK.

Eur J Cancer Prev. 2017 Mar;26(2):170-178. doi: 10.1097/CEJ.0000000000000238.

PMID:
27010329
22.

Risk of invasive cervical cancer after atypical glandular cells in cervical screening: nationwide cohort study.

Wang J, Andrae B, Sundström K, Ström P, Ploner A, Elfström KM, Arnheim-Dahlström L, Dillner J, Sparén P.

BMJ. 2016 Feb 11;352:i276. doi: 10.1136/bmj.i276.

23.

Quadrivalent HPV vaccine effectiveness against high-grade cervical lesions by age at vaccination: A population-based study.

Herweijer E, Sundström K, Ploner A, Uhnoo I, Sparén P, Arnheim-Dahlström L.

Int J Cancer. 2016 Jun 15;138(12):2867-74. doi: 10.1002/ijc.30035. Epub 2016 Mar 9. Erratum in: Int J Cancer. 2017 Jul 1;141(1):E1-E4.

24.

Incidence of herpes zoster and associated events including stroke--a population-based cohort study.

Sundström K, Weibull CE, Söderberg-Löfdal K, Bergström T, Sparén P, Arnheim-Dahlström L.

BMC Infect Dis. 2015 Oct 31;15:488. doi: 10.1186/s12879-015-1170-y.

25.

The Participation of HPV-Vaccinated Women in a National Cervical Screening Program: Population-Based Cohort Study.

Herweijer E, Feldman AL, Ploner A, Arnheim-Dahlström L, Uhnoo I, Netterlid E, Dillner J, Sparén P, Sundström K.

PLoS One. 2015 Jul 28;10(7):e0134185. doi: 10.1371/journal.pone.0134185. eCollection 2015.

26.

Interactions Between High- and Low-Risk HPV Types Reduce the Risk of Squamous Cervical Cancer.

Sundström K, Ploner A, Arnheim-Dahlström L, Eloranta S, Palmgren J, Adami HO, Ylitalo Helm N, Sparén P, Dillner J.

J Natl Cancer Inst. 2015 Jul 9;107(10). pii: djv185. doi: 10.1093/jnci/djv185. Print 2015 Oct.

27.

A coordinated cross-disciplinary research initiative to address an increased incidence of narcolepsy following the 2009-2010 Pandemrix vaccination programme in Sweden.

Feltelius N, Persson I, Ahlqvist-Rastad J, Andersson M, Arnheim-Dahlström L, Bergman P, Granath F, Adori C, Hökfelt T, Kühlmann-Berenzon S, Liljeström P, Maeurer M, Olsson T, Örtqvist Å, Partinen M, Salmonson T, Zethelius B.

J Intern Med. 2015 Oct;278(4):335-53. doi: 10.1111/joim.12391. Epub 2015 Jun 30. Review.

28.

Cervical cancer screening in Europe: Quality assurance and organisation of programmes.

Elfström KM, Arnheim-Dahlström L, von Karsa L, Dillner J.

Eur J Cancer. 2015 May;51(8):950-68. doi: 10.1016/j.ejca.2015.03.008. Epub 2015 Mar 25.

PMID:
25817010
29.

Organization and quality of HPV vaccination programs in Europe.

Elfström KM, Dillner J, Arnheim-Dahlström L.

Vaccine. 2015 Mar 30;33(14):1673-81. doi: 10.1016/j.vaccine.2015.02.028. Epub 2015 Feb 23.

PMID:
25720792
30.

Increased β-haemolytic group A streptococcal M6 serotype and streptodornase B-specific cellular immune responses in Swedish narcolepsy cases.

Ambati A, Poiret T, Svahn BM, Valentini D, Khademi M, Kockum I, Lima I, Arnheim-Dahlström L, Lamb F, Fink K, Meng Q, Kumar A, Rane L, Olsson T, Maeurer M.

J Intern Med. 2015 Sep;278(3):264-76. doi: 10.1111/joim.12355. Epub 2015 Mar 22.

31.

Quadrivalent HPV vaccination and risk of multiple sclerosis and other demyelinating diseases of the central nervous system.

Scheller NM, Svanström H, Pasternak B, Arnheim-Dahlström L, Sundström K, Fink K, Hviid A.

JAMA. 2015 Jan 6;313(1):54-61. doi: 10.1001/jama.2014.16946.

PMID:
25562266
32.

Human papillomavirus (HPV) vaccination and subsequent sexual behaviour: evidence from a large survey of Nordic women.

Hansen BT, Kjær SK, Arnheim-Dahlström L, Liaw KL, Jensen KE, Thomsen LT, Munk C, Nygård M.

Vaccine. 2014 Sep 3;32(39):4945-53. doi: 10.1016/j.vaccine.2014.07.025. Epub 2014 Jul 19.

33.

Long-term HPV type-specific risks of high-grade cervical intraepithelial lesions: a 14-year follow-up of a randomized primary HPV screening trial.

Smelov V, Elfström KM, Johansson AL, Eklund C, Naucler P, Arnheim-Dahlström L, Dillner J.

Int J Cancer. 2015 Mar 1;136(5):1171-80. doi: 10.1002/ijc.29085. Epub 2014 Jul 29.

34.

Number of human papillomavirus vaccine doses and condyloma--reply.

Ploner A, Herweijer E, Arnheim-Dahlström L.

JAMA. 2014 Jun 18;311(23):2439-40. doi: 10.1001/jama.2014.5012. No abstract available.

PMID:
24938570
35.

Long-term HPV type-specific risks for ASCUS and LSIL: a 14-year follow-up of a randomized primary HPV screening trial.

Elfström KM, Smelov V, Johansson AL, Eklund C, Naucler P, Arnheim-Dahlström L, Dillner J.

Int J Cancer. 2015 Jan 15;136(2):350-9. doi: 10.1002/ijc.28984. Epub 2014 May 30.

36.

Association of varying number of doses of quadrivalent human papillomavirus vaccine with incidence of condyloma.

Herweijer E, Leval A, Ploner A, Eloranta S, Simard JF, Dillner J, Netterlid E, Sparén P, Arnheim-Dahlström L.

JAMA. 2014 Feb 12;311(6):597-603. doi: 10.1001/jama.2014.95.

PMID:
24519299
37.

A/H1N1 antibodies and TRIB2 autoantibodies in narcolepsy patients diagnosed in conjunction with the Pandemrix vaccination campaign in Sweden 2009-2010.

Lind A, Ramelius A, Olsson T, Arnheim-Dahlström L, Lamb F, Khademi M, Ambati A, Maeurer M, Nilsson AL, Bomfim IL, Fink K, Lernmark Å.

J Autoimmun. 2014 May;50:99-106. doi: 10.1016/j.jaut.2014.01.031. Epub 2014 Jan 29.

PMID:
24485154
38.

Long term duration of protective effect for HPV negative women: follow-up of primary HPV screening randomised controlled trial.

Elfström KM, Smelov V, Johansson AL, Eklund C, Nauclér P, Arnheim-Dahlström L, Dillner J.

BMJ. 2014 Jan 16;348:g130. doi: 10.1136/bmj.g130.

39.

Guillain-Barré syndrome and adjuvanted pandemic influenza A (H1N1) 2009 vaccines: a multinational self-controlled case series in Europe.

Romio S, Weibel D, Dieleman JP, Olberg HK, de Vries CS, Sammon C, Andrews N, Svanström H, Mølgaard-Nielsen D, Hviid A, Lapeyre-Mestre M, Sommet A, Saussier C, Castot A, Heijbel H, Arnheim-Dahlström L, Sparen P, Mosseveld M, Schuemie M, van der Maas N, Jacobs BC, Leino T, Kilpi T, Storsaeter J, Johansen K, Kramarz P, Bonhoeffer J, Sturkenboom MC.

PLoS One. 2014 Jan 3;9(1):e82222. doi: 10.1371/journal.pone.0082222. eCollection 2014.

40.

Current cervical cancer prevention strategies including cervical screening and prophylactic human papillomavirus vaccination: a review.

Elfström KM, Herweijer E, Sundström K, Arnheim-Dahlström L.

Curr Opin Oncol. 2014 Jan;26(1):120-9. doi: 10.1097/CCO.0000000000000034. Review.

PMID:
24248011
41.
42.

Quadrivalent human papillomavirus vaccine effectiveness: a Swedish national cohort study.

Leval A, Herweijer E, Ploner A, Eloranta S, Fridman Simard J, Dillner J, Young C, Netterlid E, Sparén P, Arnheim-Dahlström L.

J Natl Cancer Inst. 2013 Apr 3;105(7):469-74. doi: 10.1093/jnci/djt032. Epub 2013 Mar 13.

44.

Incidence of genital warts in Sweden before and after quadrivalent human papillomavirus vaccine availability.

Leval A, Herweijer E, Arnheim-Dahlström L, Walum H, Frans E, Sparén P, Simard JF.

J Infect Dis. 2012 Sep 15;206(6):860-6. doi: 10.1093/infdis/jis405. Epub 2012 Jul 18.

PMID:
22815381
45.

Prospective seroepidemiologic study of human papillomavirus and other risk factors in cervical cancer.

Arnheim Dahlström L, Andersson K, Luostarinen T, Thoresen S, Ögmundsdottír H, Tryggvadottír L, Wiklund F, Skare GB, Eklund C, Sjölin K, Jellum E, Koskela P, Wadell G, Lehtinen M, Dillner J.

Cancer Epidemiol Biomarkers Prev. 2011 Dec;20(12):2541-50. doi: 10.1158/1055-9965.EPI-11-0761. Epub 2011 Oct 12.

46.

Prospective study of human papillomavirus (HPV) types, HPV persistence, and risk of squamous cell carcinoma of the cervix.

Sundström K, Eloranta S, Sparén P, Arnheim Dahlström L, Gunnell A, Lindgren A, Palmgren J, Ploner A, Sanjeevi CB, Melbye M, Dillner J, Adami HO, Ylitalo N.

Cancer Epidemiol Biomarkers Prev. 2010 Oct;19(10):2469-78. doi: 10.1158/1055-9965.EPI-10-0424. Epub 2010 Jul 29.

Supplemental Content

Loading ...
Support Center